IsoRay, Inc.
(NYSE Amex Equities : ISR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -1.83%45.710.0%$248.51m
VRXValeant Pharmaceuticals International, Inc. 0.49%28.7314.1%$169.05m
HZNPHorizon Therapeutics Plc -0.01%116.455.5%$129.22m
ICLRICON plc 0.14%277.522.8%$118.43m
CTLTCatalent, Inc. 0.22%132.602.0%$92.83m
JAZZJazz Pharmaceuticals Plc 0.49%144.842.1%$90.49m
PRGOPerrigo Co. Plc -0.39%45.616.9%$73.61m
UTHRUnited Therapeutics Corp. 0.18%191.0114.0%$67.59m
ARGXargenx SE -0.34%293.160.0%$40.31m
GRVIGrove, Inc. -2.11%6.040.0%$37.95m
AXSMAxsome Therapeutics, Inc. -1.76%40.101.8%$37.93m
BHCBausch Health Cos., Inc. 0.49%28.730.0%$34.17m
ENDPEndo International Plc 0.44%4.568.5%$31.70m
RVNCRevance Therapeutics, Inc. -2.03%15.446.1%$31.59m
PCRXPacira Biosciences, Inc. -0.96%52.619.8%$30.82m

Company Profile

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.